Vigil Neuroscience, Inc., (VIGL): Price and Financial Metrics


Vigil Neuroscience, Inc., (VIGL): $12.00

-0.09 (-0.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VIGL to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

VIGL Stock Price Chart Interactive Chart >

Price chart for VIGL

VIGL Price/Volume Stats

Current price $12.00 52-week high $18.27
Prev. close $12.09 52-week low $2.18
Day low $11.69 Volume 16,549
Day high $12.49 Avg. volume 19,721
50-day MA $11.74 Dividend yield N/A
200-day MA $8.43 Market Cap 426.97M

Vigil Neuroscience, Inc., (VIGL) Company Bio


Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. The company was incorporated in 2020 and is based in Cambridge, Massachusetts.


VIGL Latest News Stream


Event/Time News Detail
Loading, please wait...

VIGL Latest Social Stream


Loading social stream, please wait...

View Full VIGL Social Stream

Latest VIGL News From Around the Web

Below are the latest news stories about VIGIL NEUROSCIENCE INC that investors may wish to consider to help them evaluate VIGL as an investment opportunity.

Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that Ivana Magovčević-Liebisch, Ph.D., J.D., President and Chief Executive Officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, at 8:15 a.m. PT / 11:15 a.m. ET. To access a live webcast o

Yahoo | January 3, 2023

Vigil Neuroscience Appoints David Gray, Ph.D., as Chief Scientific Officer and Announces Changes to Executive Team

– Dr. David Gray brings nearly 20 years of preclinical and clinical research and drug development expertise in neurological diseases – – Dr. Spyros Papapetropoulos to depart Vigil to pursue a Chief Executive Officer opportunity – CAMBRIDGE, Mass., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that David Gray, Ph.D., wi

Yahoo | December 15, 2022

Vigil Neuroscience Announces First Patient Dosed in the IGNITE Phase 2 Clinical Trial to Evaluate VGL101 in Patients with ALSP

First-ever interventional trial for patients with ALSP, a rare and rapidly progressing neurological disease with significant unmet medical needCAMBRIDGE, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that the Company dosed its first patient in the Phase 2, proof-of-concept clinical trial evaluating VGL101, a ful

Yahoo | December 14, 2022

We Think Vigil Neuroscience (NASDAQ:VIGL) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Yahoo | November 29, 2022

Vigil Neuroscience to Host ALSP KOL Event on December 6, 2022

CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that the Company will host an adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) Key Opinion Leader (KOL) event for the investment community in New York City on Tuesday, December 6, 2022, from 8:30 a.m. – 11:30 a.m. ET. The eve

Yahoo | November 28, 2022

Read More 'VIGL' Stories Here

VIGL Price Returns

1-mo -0.33%
3-mo 27.93%
6-mo 51.52%
1-year -14.71%
3-year N/A
5-year N/A
YTD -4.00%
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7203 seconds.